E2dg

E2DG is specialized in the early stage development of new molecules and target-oriented compounds in oncology,onco-hematology and immunology. With strong preclinical and pharmacological capabilities, broad expertise on the early development and experienced medical imput, we offer professional assistance on drug development approaches, lead positioning, design of clinical studies and regulatory strategies to maximize the chance of project success. We optimize and accelerate your R&D programs, based on our drug positioning-oriented philosophy.